Gilead’s HIV Drug Prevents Infection With One Shot A Year Instead Of Two

Gilead's HIV Drug Prevents Infection With One Shot A Year Instead Of Two

Source: Kaiser Health News

The company is planning a Phase 3 trial for the new formulation of lenacapavir, Stat reports. Other pharma and technology news is on microplastics and the spread of antibiotic-resistant superbugs; a successful artificial titanium heart trial; AI in hospitals; and more.

Gilead’s HIV Drug Prevents Infection With One Shot A Year Instead Of Two
The company is planning a Phase 3 trial for the new formulation of lenacapavir, Stat reports. Other pharma and technology news is on microplastics and the spread of antibiotic-r… [5329 chars]

Read more